The Drugs for Neglected Diseases initiative (DNDi), has joined Vivli as a member to share its valuable datasets.

“We are delighted to include these important studies from DNDi on Vivli,” said Rebecca Li, Vivli CEO. “Vivli is excited to work with DNDi to make it easy and efficient for researchers to access these data.”

DNDi is an international, not-for-profit research and development organization. It discovers, develops, and delivers treatments for neglected patients around the world. Its treatments are affordable and patient-friendly – and have already saved millions of lives.

“Vivli is a leading data-sharing platform and DNDi is committed to open science,” said Dr Craig Tipple, Medical Director at DNDi. “By working together to share DNDi’s clinical study data, we can optimize the public health and scientific benefits of our research, meet our ethical and scientific obligations for data transparency, and, we hope, accelerate the development of new medicines for neglected diseases.”

For more information about the studies DNDi will share on Vivli, please visit their member page. For additional information about Vivli membership, learn more here.